Articles

• Select this article
  • Anthony Howell

  The normal breast: cancer risk and prevention – an overview

  Endocr Relat Cancer 4 (1) 1-5, doi:10.1677/erc.0.0040001
  • Extract
  • Full Text (PDF)
• Select this article
  • J Russo and
  • I H Russo

  Role of differentiation in the pathogenesis and prevention of breast cancer

  Endocr Relat Cancer 4 (1) 7-21, doi:10.1677/erc.0.0040007
  • Extract
  • Full Text (PDF)
• Select this article
  • E Anderson,
  • R B Clarke,
  • and A Howell

  Changes in the normal human breast throughout the menstrual cycle: relevance to breast carcinogenesis

  Endocr Relat Cancer 4 (1) 23-33, doi:10.1677/erc.0.0040023
  • Extract
  • Full Text (PDF)
• Select this article
  • R C Coombes,
  • L Buluwela,
  • and J J Gomm

  The role of myoepithelial-derived growth factors in the human breast

  Endocr Relat Cancer 4 (1) 35-43, doi:10.1677/erc.0.0040035
  • Abstract
  • Full Text (PDF)
• Select this article
  • C H Streuli,
  • C Dive,
  • J A Hickman,
  • N Farrelly,
  • and A Metcalfe

  Control of apoptosis in breast epithelium

  Endocr Relat Cancer 4 (1) 45-53, doi:10.1677/erc.0.0040045
  • Extract
  • Full Text (PDF)
• Select this article
  • G R Merlo,
  • L Fiore,
  • F Basolo,
  • K Woods-Cook,
  • and N E Hynes

  In mammary epithelial cells p53-mediated apoptosis in response to DNA damage is dependent on the agent and can be influenced by growth factors

  Endocr Relat Cancer 4 (1) 55-66, doi:10.1677/erc.0.0040055
  • Abstract
  • Full Text (PDF)
• Select this article
  • B Gusterson,
  • W Cui,
  • M Iwobi,
  • M R Crompton,
  • G Harold,
  • S Hobbs,
  • T Kamalati,
  • R Knox,
  • C Neil,
  • F Yull,
  • B Howard,
  • and A J Clark

  Selective cell ablation in the mammary gland of transgenic mice

  Endocr Relat Cancer 4 (1) 67-74, doi:10.1677/erc.0.0040067
  • Abstract
  • Full Text (PDF)
• Select this article
  • W J Muller,
  • D L Dankort,
  • P M Siegel,
  • and M A Webster

  Oncogene-mediated signal transduction in transgenic mouse models of human breast cancer

  Endocr Relat Cancer 4 (1) 75-84, doi:10.1677/erc.0.0040075
  • Extract
  • Full Text (PDF)
• Select this article
  • F J DeMayo,
  • J P Lydon,
  • O M Conneely,
  • and B W O'Malley

  How can studies on knockout mice help in our understanding of normal and abnormal breast development?

  Endocr Relat Cancer 4 (1) 85-92, doi:10.1677/erc.0.0040085
  • Abstract
  • Full Text (PDF)
• Select this article
  • S R Lakhani

  Is there a benign to malignant progression?

  Endocr Relat Cancer 4 (1) 93-104, doi:10.1677/erc.0.0040093
  • Extract
  • Full Text (PDF)
• Select this article
  • D L Page,
  • W D Dupont,
  • J T Holt,
  • and R A Jensen

  Directions and associations in premalignant breast disease: the important role of non-comedo ductal carcinoma in situ

  Endocr Relat Cancer 4 (1) 105-112, doi:10.1677/erc.0.0040105
  • Extract
  • Full Text (PDF)
• Select this article
  • S H Safe and
  • A McDougal

  Environmental factors and breast cancer

  Endocr Relat Cancer 4 (1) 113-123, doi:10.1677/erc.0.0040113
  • Extract
  • Full Text (PDF)
• Select this article
  • M C Pike,
  • J R Daniels,
  • and D V Spicer

  A hormonal contraceptive approach to reducing breast and ovarian cancer risk: an update

  Endocr Relat Cancer 4 (1) 125-133, doi:10.1677/erc.0.0040125
  • Abstract
  • Full Text (PDF)
• Select this article
  • T J Powles and
  • J Chang

  Chemoprevention of breast cancer: why is tamoxifen not the answer?

  Endocr Relat Cancer 4 (1) 135-139, doi:10.1677/erc.0.0040135
  • Extract
  • Full Text (PDF)